|
MTDH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.408800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.558770E-01 |
| Normal-vs-Stage2 |
4.629400E-01 |
| Normal-vs-Stage3 |
4.957600E-02 |
| Normal-vs-Stage4 |
2.240000E-01 |
| Stage1-vs-Stage2 |
1.679980E-01 |
| Stage1-vs-Stage3 |
5.099400E-03 |
| Stage1-vs-Stage4 |
1.514610E-01 |
| Stage2-vs-Stage3 |
3.507200E-01 |
| Stage2-vs-Stage4 |
3.330200E-01 |
| Stage3-vs-Stage4 |
5.502000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.876600E-01 |
| Normal-vs-AfricanAmerican |
9.457200E-01 |
| Normal-vs-Asian |
5.798800E-01 |
| Caucasian-vs-AfricanAmerican |
6.584400E-01 |
| Caucasian-vs-Asian |
3.615800E-01 |
| AfricanAmerican-vs-Asian |
4.325400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.722100E-02 |
| Normal-vs-Female |
6.017300E-03 |
| Male-vs-Female |
1.221970E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.428400E-01 |
| Normal-vs-Extreme_Weight |
6.072500E-02 |
| Normal-vs-Obese |
2.621400E-01 |
| Normal-vs-Extreme_Obese |
1.243900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.222000E-01 |
| Normal_Weight-vs-Obese |
5.490400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.260300E-02 |
| Extreme_Weight-vs-Obese |
1.857710E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.116200E-01 |
| Obese-vs-Extreme_Obese |
1.387670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.546300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.996200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.938300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.752600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.943700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.013600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.794400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.538700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.492800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.866000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.367700E-02 |
| Normal-VS-Type2 PRCC |
7.737600E-01 |
| Normal-VS-KIRP CIMP |
5.421900E-02 |
| Normal-VS-Unclassified PRCC |
4.106000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.754500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.488500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.453500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.141700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.694600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.221900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.087600E-01 |
| Normal-vs-N1 |
1.661640E-02 |
| Normal-vs-N2 |
3.237200E-01 |
| N0-vs-N1 |
5.082400E-03 |
| N0-vs-N2 |
2.827800E-01 |
| N1-vs-N2 |
5.791200E-01 |
|
|
